China NT Pharma Group Company Ltd banner
C

China NT Pharma Group Company Ltd
HKEX:1011

Watchlist Manager
China NT Pharma Group Company Ltd
HKEX:1011
Watchlist
Price: 0.69 HKD Market Closed
Market Cap: HK$465.2m

China NT Pharma Group Company Ltd
Investor Relations

China NT Pharma Group Co., Ltd. is a pharmaceutical company, which engages in the distribution, promotion, manufacturing as well as research and development of pharmaceuticals and vaccines. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2011-04-20. The firm mainly conducts its businesses through two segments. The Proprietary Product Production and Sales segment is engaged in the production and sales of NT branded products and generic drugs through its subsidiaries. The Miacalcic segment is engaged in the sales and marketing of miacalcic injectable and nasal spray branded products for treatment of bone pain caused by osteolysis and lower bone mass, as well as sub-licensing of intellectual property rights and distribution rights.

Show more
Loading
1011
Hang Seng (Hong Kong)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Tit Ng
Co-Founder, Chairman & CEO
No Bio Available
Ms. Jing Fang
Chief Financial Officer
No Bio Available
Ms. Ching Mei Ng
Executive Director
No Bio Available
Mr. Cheung King Cheng
Company Secretary
No Bio Available

Contacts

Address
JIANGSU
Suzhou
No. 1 Hualing Street, Suzhou Industrial Park
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett